10226-40-1

Basic information

• Product Name: 2-Propenoic acid, 3-(5-methoxy-2-nitrophenyl)-
• CAS NO: 10226-40-1
• Molecular Formula: C10H9NO5
• Molecular Weight: 223.185
• Mol File: 10226-40-1.mol

Chemical Properties

• CAS DataBase Reference: 2-Propenoic acid, 3-(5-methoxy-2-nitrophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propenoic acid, 3-(5-methoxy-2-nitrophenyl)-(10226-40-1)
• EPA Substance Registry System: 2-Propenoic acid, 3-(5-methoxy-2-nitrophenyl)-(10226-40-1)

Safety Data

• Hazardous Substances Data: 10226-40-1(Hazardous Substances Data)

Upstream product

• 141-82-2 malonic acid 
• 20357-24-8 5-methoxy-2-nitro-benzaldehyde 
• 42454-06-8 2-nitro-5-hydroxybenzaldehyde 
• 6099-04-3 trans-3-methoxycinnamic acid 
• 7697-37-2 nitric acid 
• 587-04-2 m-Chlorobenzaldehyde 
• 99-61-6 3-nitro-benzaldehyde 
• 6628-86-0 5-chloro-2-nitrobenzaldehyde 
• 67-56-1 methanol 
• 20357-28-2 5-chloro-2-nitro-cinnamic acid 

Downstream Products

• 10226-41-2 5-methoxy-2-aminocinnamic acid 
• 65300-92-7 trans-3-(5-methoxy-2-cyanophenyl)propenoic acid 
• 21962-52-7 2-formyl-4-methoxy-benzonitrile 
• 856356-96-2 2-ethynyl-4-methoxy-1-nitrobenzene 
• 20567-53-7 (5-methoxy-2-nitro-phenyl)-propiolic acid 
• 54197-64-7 6-methoxy-2-oxo-1,2,3,4-tetrahydroquinoline 
• 20567-48-0 (+/-)-2r_F.3c_F-dibromo-3cat_F-(6-nitro-3-methoxy-phenyl)-propionic acid 
• 142010-17-1 methyl (E)-3-(5′-methoxy-2′-nitrophenyl)acrylate 

Relevant articles and documents

New procedure for the total synthesis of cilostamide

An efficient route to synthesise a wide range of N,N-R,R-4-(2-oxo-1,2- dihydroquinolin-6-yloxy)butanamide, specially Cilostamide (R = methyl and R = cyclohexyl), one of the most selective inhibitors of phosphodiesterase3 (PDE3) enzyme, from 5-methoxy-2-ni

Studies on new platelet aggregation inhibitors 1. Synthesis of 7-nitro-3,4-dihydroquinoline-2(1H)-one derivatives

A series of 6-cyclic aliphatic amino-7-nitro-3,4-dihydroquinoline-2(1H)-ones were prepared and tested for platelet aggregation inhibitory effect, cardiotonic activity and chronotropic activity. These compounds appeared to show selective inhibitory activity against platelet aggregation. Among them, 6-(4-ethoxycarbonylpiperidino)-7-nitro-3,4-dihydroquinoline-2(1H)-one (22f) showed the most potent inhibitory activity and high selectivity. A divergent synthetic route to 6-cyclic aliphatic amino-7-nitro-3,4-dihydroquinoline-2(1H)-one derivatives has also been investigated.